DrugPatentWatch Database Preview

Innogenix Company Profile

« Back to Dashboard

What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?

INNOGENIX has four approved drugs.

Summary for Innogenix

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	4

Drugs and US Patents for Innogenix

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Innogenix	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	075215-002	Jul 29, 1999	AB	RX	No	No
Innogenix	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	078953-001	Apr 15, 2010	AP	RX	No	No
Innogenix	PILOCARPINE HYDROCHLORIDE	pilocarpine hydrochloride	TABLET;ORAL	076963-001	Dec 22, 2004	AB	RX	No	No
Innogenix	PILOCARPINE HYDROCHLORIDE	pilocarpine hydrochloride	TABLET;ORAL	076963-002	Feb 27, 2007	AB	RX	No	No
Innogenix	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	075215-001	Jul 29, 1999	AB	RX	No	No
Innogenix	METRONIDAZOLE	metronidazole	TABLET;ORAL	070772-001	Jul 16, 1986	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Innogenix